Research / ESCA / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-26-006094 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
7.68% · OPTIONAL · VALID
Capex intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.05% · OPTIONAL · VALID
Operating cash generation 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.91% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-4.51% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
28.51% · OPTIONAL · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
7.80% · CORE · VALID
R&D intensity 100th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.33% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.69% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 46 states Self-history eligible
Mar 19, 2022 7/7 normalized Level 3 Jul 9, 2022 7/7 normalized Level 3 Oct 1, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 29.86%
Current 7.68%
Delta -22.17% Capex Intensity Increased
Previous 0.43%
Current 1.05%
Delta 0.62% Cash Generation Increased
Previous -1.42%
Current 12.91%
Delta 14.34% Growth Decreased
Previous 0.07%
Current -4.51%
Delta -4.58% Inventory Pressure Decreased
Previous 119.00%
Current 28.51%
Delta -90.48% Profitability Decreased
Previous 10.77%
Current 7.80%
Delta -2.97% Sbc Intensity Decreased
Previous 0.75%
Current 0.69%
Delta -0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.